Abstract
The paper presents a summary of the literature that includes the results of the research on the echocardiographic parameters for the early detection and monitoring of the cardiac toxicity of the antitumor treatment. While the left ventricular ejection fraction is currently the most widely used index to quantify cardiac function in cardio-oncology, there are a number of indices under investigation to prove their prognostic value in the occurrence of adverse cardiac events during cancer therapy. Such indices derived from the Doppler method, speckle tracking parameters, strain rate as well as parameters derived from three-dimensional echocardiography, which can provide additional sensitivity and substantial prognostic value for future cardiovascular events.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Bulletin of the Academy of Sciences of Moldova. Medical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
